Prestige EHV - 1/4

EQUINE RHINOPNEUMONITIS VACCINE, KILLED VIRUS

A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine herpesvirus types 1 and 4 (EHV-1 and EHV-4).

Prestige EHV - 1/4 Indications

This product has been shown to be effective for the vaccination of healthy horses 6 months of age or older against EHV-1 and EHV-4. Duration of Immunity has not been established. For more information regarding safety and efficacy data, go to productdata.aphis.usda.gov.

This product has been shown to be effective against virus shedding of EHV-1 and EHV-4.

DOSE: For primary vaccination aseptically administer 1 mL intramuscularly, repeat with a single dose in 4 - 6 weeks. Historically, annual revaccination with this product has been recommended. The need for this booster has not been established. For more information on revaccination frequency consult your veterinarian.

CAUTIONS: Store at 2°-8°C (35°-46°F). Shake well before using. Use entire contents when first opened. Do not mix with other products. This product has not been tested in pregnant animals. Do not vaccinate within 21 days before slaughter. Inject deep into the muscle only. Local reactions may occur at the injection sites in vaccinates. Systemic reactions may also occur in animals following vaccination. If allergic reaction occurs, treat with epinephrine. Care should be used to avoid injecting your own fingers, hands, or other body parts. Accidental injection can cause serious local reactions. In case of human exposure, contact a physician.

ANTIBIOTIC: Gentamicin.

PRESERVATIVE: Thimerosal.

FOR ANIMAL USE ONLY

Intervet Inc. d/b/a Merck Animal Health, Omaha, NE 68103, USA

VLN 165A/PCN 1525.22

1 800 521-5767 (USA)

1 866 683-7838 (CAN)

For patent information:

http://www.merck.com/product/patent/home.html

CPN: 1047542.1